Prattes, Juergen
University of Cologne · Medical University of Graz · BioTechMed-Graz
7 papers on CoChatORCID 0000-0001-5751-9311
Most cited papers
- Verified
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 467
- Verified
Performance of Galactomannan, Beta- d -Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis
Hoenigl, M., Prattes, J., Spiess, B., Wagner, J., Prueller, F., Raggam, R. B., Posch, V., Duettmann, W., Hoenigl, K., Wölfler, A., et al. (2014) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing
Cited by 233
- Verified
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
Hoenigl, M., Salmanton-García, J., Egger, M., Gangneux, J.-P., Bicanic, T., Arikan-Akdagli, S., Alastruey-Izquierdo, A., Klimko, N., Barac, A., Özenci, V., et al. (2023) · The Lancet Infectious Diseases
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 152
- Verified
Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples
Heldt, S., Prattes, J., Eigl, S., Spiess, B., Flick, H., Rabensteiner, J., Johnson, G., Prüller, F., Wölfler, A., Niedrist, T., et al. (2018) · Journal of Infection
Antifungal resistance and susceptibilityNeutropenia and Cancer Infections
Cited by 110
- Verified
Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis
Hoenigl, M., Egger, M., Price, J., Krause, R., Prattes, J., & White, P. L. (2023) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing
Cited by 51
- Verified
Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
Salzer, H. J. F., Prattes, J., Flick, H., Reimann, M., Heyckendorf, J., Kalsdorf, B., Obersteiner, S., Gaede, K. I., Herzmann, C., Johnson, G. L., et al. (2018) · Frontiers in Microbiology
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 41
- Verified
Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit
Reisinger, A. C., Niedrist, T., Posch, F., Hatzl, S., Hackl, G., Prattes, J., Schilcher, G., Meißl, A.-M., Raggam, R. B., Herrmann, M., et al. (2021) · Scientific Reports
Sepsis Diagnosis and TreatmentInflammation biomarkers and pathways
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free